![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.pharmacompass.com/pdf/news/zhejiang-tianyu-pharmaceutical-co-limited-on-health-canada-inspection-list-48637.pdf
https://www.fiercepharma.com/manufacturing/fda-blasts-chinese-drug-ingredients-outfit-subpar-impurity-testing-and-poor-equipment
https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/zhejiang-tianyu-pharmaceutical-co-ltd-631054-08172022
https://endpts.com/manufacturing-sites-in-germany-and-china-hit-with-warning-letters-over-qc-and-cleaning-issues/
https://www.raps.org/news-and-articles/news-articles/2018/9/eu-us-ban-manufacturer-use-of-valsartan-from-chin?utm_source=MagnetMail&utm_medium=Email%20&utm_campaign=RF%20Today%20%7C%2028%20September
https://www.pharmacompass.com/pdf/news/EMA-review-of-impurities-in-sartan-medicines-1538045187.pdf
https://www.ema.europa.eu/documents/press-release/update-medicines-containing-valsartan-zhejiang-tianyu_en.pdf
https://www.raps.org/news-and-articles/news-articles/2018/8/eu-suspends-chinese-company-from-manufacturing-val?utm_source=MagnetMail&utm_medium=Email%20&utm_campaign=RF%20Today%20%7C%2020%20August
https://www.swissmedic.ch/swissmedic/en/home/news/mitteilungen/investigation-of-valsartan-update.html
https://www.pharmacompass.com/pdf/news/update-on-review-of-valsartan-medicines-due-to-detection-of-ndma-1538038404.pdf